InfuSystem Holdings, Inc.
Every calculator, already run for INFU
Open the full toolkit →You have the numbers on INFU. Get the argument.
A written report on which of these readings actually decide the outcome for InfuSystem Holdings, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
3 analysts covering INFUAnalyst Price Target Disagreement for InfuSystem Holdings, Inc.
Wall Street's bull case implies +40% from the current price; the bear case implies +17%. Analysts are relatively aligned on INFU's range.
Ownership & short interest
Insider Trading Activity for INFU
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintena…
INFU — frequently asked
Is INFU a buy right now?
Wall Street's consensus rating on InfuSystem Holdings, Inc. is Strong Buy across 3 analysts, with a mean price target of $16.83 (+31% vs. the current $12.85). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is INFU overvalued?
INFU trades at 32.1x trailing earnings, against a DCF fair value of $8 per share. The current price implies 13% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is INFU's next earnings date?
InfuSystem Holdings, Inc. is next scheduled to report earnings around Nov 3, 2026. A full INFU research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for InfuSystem Holdings, Inc.?
Analysts covering InfuSystem Holdings, Inc. (INFU) range from a bear-case target of $15.00 to a bull-case high of $18.00, with a mean consensus target of $16.83 across 3 analysts. The spread of $3.00 (23% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare InfuSystem Holdings, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For InfuSystem Holdings, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full INFU research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on InfuSystem Holdings, Inc., in minutes. 3 free reports included with every account — no credit card required.